Table 1 Epidemiological measures of the frequency of interval breast cancers in population mammography screening

From: The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening

Study first author

Screening settinga; age-group screened

Cancer detection rate per 10,000 screens

Interval cancer rate per 10,000 screens reported for all screens: overall or by inter-screen interval

Interval cancer rate per 10,000 screens where reported separately for initial and repeat screens

Proportional interval cancer rateb

Percentage of cancers (from all BCs in screened women) that are interval cancersc

Weber13

Southern screening region of Dutch program (2000–11), 302,699 film-screen and 115,047 digital mammograms; 50–75 years

Digital 69 Film-screen 52

Digital 17 Film-screen 20

Digital 19.4% Film-screen 28%

O'Brien4

Irish population breast screening program (2000–07); 50–64 years

53.6 (initial 66.9; repeat 41.4)

Overall 19.2 year 1: 5.8 year 2: 13.4

Initial 19.6 Repeat 18.9

40%

26%

Henderson21

Breast Cancer Surveillance Consortium, USA (2003–11), 3,021,515 mammograms (40.3% digital, 59.7% film); 40–89 years

Digital 44.7 Film-screen 44.2

12-month interval: Digital 7.3 Film-screen 7.9

14.7% (annual screening)

Carbonaro15

Milan, Italy, population breast screening program (2001–06); 49–69 years

55.2

Overall 17.0

29.0% (initial 19%; repeat 39%)

23.3%

Renart-Vicens26

Girona, Spain, Health Region screening program (2000–06), 50–69 years

49.0

Overall 7.0

Range 9.3 to 47.7%

13%

Fong18

Breast Test Wales screening program (1998–2001); 50–64 years

51.0

Overall 34.8

38% (3-yearly screening)

Heidinger20

German mammography screening program/North Rhine-Westphalia cancer registry (2005–08), 50–69 years

[study of initial screening round] 81.0

Overall 23.2 Year 1: 7.4 Year 2: 15.7

(all data are for initial screens)

Year 1: 27% Year 2: 58%

22%

Bennett16

National Health Service breast screening programme England, Wales, and Northern Ireland (1997–2003); 50–64 years

60.4

Overall 29.1 year 1: 5.5 year 2: 11.3 year 3: 12.2

32.5% (3-yearly screening)

Tornberg28

Navarra, Spain, population screening (1990–96); 45–65 years

41.5 (initial 63.0; repeat 31.3)

Overall 8.4d year 1: 2.1d year 2: 6.3d

Initial 7.2e Repeat 9.0e

25.9%d (initial 22%; repeat 28%)e

17%d

Seigneurin27

Isere, France, population screening – time frames are for change from 1-view to 2-view mammography: (2002–04) 50–69 years; (1994–99) 50–69 years

2002–04: 70.4 1994–99: 53.0

2002–04: Overall 15.3 year 1: 3.2 1994–99: Overall 23.9 year 1: 6.8

2002–04: Initial 17.3 Repeat 13.6 1994–99: Initial 24.7 Repeat 23.2

2002–04: 31.2%d 1994–99: 48.7%d

2002–04: 17.8% 1994–99: 31%

Bordas17

Norrbotten, Sweden, population screening program (1989–2002); 40–74 years

29.4

Overall 10.7 year 1: 5.1 year 2: 5.6

33.4%d

26.6%

Tornberg28

Florence, Italy, population screening program (1990–94); 50–69 years

77.1 (initial 91.0; repeat 40.1)

Overall 15.3 year 1: 3.9 year 2: 11.4

Initial 13.3e Repeat 21.0e

34.4%d (initial 30%; repeat 47%)e

17%d

Tornberg28

Turin, Italy, population screening program (1992–96); 50–59 years

78.7 (initial 86.1; repeat 62.6)

Overall 15.5 year 1: 5.5 year 2: 10.0

Initial 14.0e Repeat 19.2e

35.0%d (initial 35%; repeat 47%)e

16%d

Fracheboud19

Netherlands population screening program (1990–93); 50–69 years

57.3 (initial 65.7, repeat 34.6)

Overall 18.2d year 1: 6.1d year 2: 12.1d

Initial 18.1 Repeat 18.6

39.3%d

24%d

Törnberg28

Marseille, France, population screening (1993–98); 50–69 years

46.7 (initial 46.5; repeat 47.3)

Overall 17.4 year 1: 5.4 year 2: 12.1

Initial 17.3e Repeat 18.1e

43.3%d (initial 43%; repeat 45%)e

27%d

Törnberg28

Strasbourg, France, population screening (1989–97); 50–65 years

42.7 (initial 51.9; repeat 37.2)

Overall 21.3 year 1: 6.9 year 2: 14.4

Initial 20.5e Repeat 22.0e

47.2%d (initial 45%; repeat 49%)e

33%d

Törnberg28

Four counties, Norway (1996–97); 50–69 years

67.2

Overall 19.5 year 1: 4.5 year 2: 15.0

Initial 16.4e Repeat n/a

48.7%d (initial 41%; repeat n/a)e

22%d

Törnberg28

Pirkanmaa, Finland (1988–99); 50–69 years

36.3 (initial 41.6; repeat 32.3)

Overall 17.4 year 1: 6.5 year 2: 11.0

66.4%d

32%d

Lynge24

Copenhagen, Denmark (1991–93 [initial] and 1993–95 [repeat]); 50–69 years

(Initial 118.6; repeat 62.5)b

Initial 17.3e Repeat 20.5e

(Initial 34%; repeat 40%)e

Initial 13% Repeat 25%

Njor25

Funen, Denmark (1993–95 [initial] and 1996–97 [repeat]); 50–69 years

(Initial 95.9; repeat 52.1)b

Initial 21.2e Repeat 24.2e

(Initial 43%; repeat 47%)e

Initial 18% Repeat 32%

Törnberg28

Stockholm, Sweden, screening program (1989–97); 50–69 years

47.6 (initial 58.9; repeat 39.8)

Overall 21.1 year 1: 7.3 year 2: 13.8

Initial 20.4e Repeat 21.7e

(Initial 40%; repeat 46%)e

Initial 26% Repeat 35%

Hofvind22

Norwegian breast cancer screening program (1996–2005 [initial] and 1988–2005 [repeat]); 50–69 years

56.4 (initial 64.8; repeat 49.2)

18.2

Initial 18.3 Repeat 18.2

51%e

Initial 22% Repeat 27%

Kellen23

Belgian province of Limburg population screening program (1996–2001); 50–69 years

101 (included prevalent screening)

Overall 49.3 (for 3-year interval)

Year 1: 21.7% Year 2: 11.3%

36.6% (biennial program but included 3-year interval BC data)

Vettorazzi29

Screening program in local health units of Veneto Region, Italy (1999–2002); 50–69 years

[initial screening round] 72.0e

(all data are for initial screens) 16.3e

29% (year 1: 21%;year 2: 46%)

18%

  1. a Except where specified as including data for digital mammography, data are for film-screen mammography. Screening is biennial unless otherwise specified
  2. b The ratio of the interval cancer rate to the expected underlying incidence rate (also referred to as proportionate incidence)
  3. c Percentage is a simple representation of the proportion of breast cancers occurring in screened women (counting both screen-detected and interval cases in the denominator) that are recorded as interval cancers, and can also be expressed as a ratio (also referred to as an 'interval cancer ratio'2)
  4. d Based on data from O'Brien et al.4
  5. e Based on data from Andersen et al.2